Immunocore Holdings plc (IMCR)
NASDAQ: IMCR · Real-Time Price · USD
28.52
+0.36 (1.28%)
May 4, 2026, 4:00 PM EDT - Market closed

Immunocore Holdings Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-76.8-120.64-107.68-102.42-180.03
Depreciation & Amortization
10.0217.8210.8412.757.59
Stock-Based Compensation
75.467.8165.6265.6248.89
Other Adjustments
-7.29-10.071.44-26.992.4
Change in Receivables
-21.41-35.15-39.53-65.09-4.86
Changes in Accounts Payable
5.0580.1144.5651.791.47
Changes in Accrued Expenses
15.8971.539.0941.7610.68
Changes in Income Taxes Payable
-4.64-129.99-1.5-
Changes in Unearned Revenue
-0.77-0-24.18-75.35-29.07
Changes in Other Operating Activities
-18.34-27.95-17.11-18.37-0.18
Operating Cash Flow
-10.7126.062.94-49.21-143.11
Operating Cash Flow Growth
-786.43%---
Capital Expenditures
-4.34-5.17-5.43-2.2-1.39
Sale of Property, Plant & Equipment
-0.04-0.010.11
Purchases of Intangible Assets
---1.5-0.5-
Purchases of Investments
-30-350---
Proceeds from Sale of Investments
18----
Other Investing Activities
15.2123.6416.55.77-
Investing Cash Flow
-16.34-684.094.42-1.96-1.28
Long-Term Debt Issued
-798.72-50-
Long-Term Debt Repaid
-4.94-56.67-4.6-55.88-
Net Long-Term Debt Issued (Repaid)
-4.94742.05-4.6-5.88-
Issuance of Common Stock
12.3713.5269.25299.91288.19
Net Common Stock Issued (Repurchased)
12.3713.5269.25299.91288.19
Other Financing Activities
-10.06-36.07-5.07-10.12-
Financing Cash Flow
12.37667.259.58283.91288.19
Effect of Exchange Rate Changes on Cash and Cash Equivalents
26.66-1.718.29-12.650.63
Net Cash Flow
-30.6416.5264.39201.41143.8
Free Cash Flow
-15.0520.89-2.49-51.41-144.49
FCF Margin
-3.76%6.73%-1.00%-29.49%-396.04%
Free Cash Flow Per Share
-0.300.42-0.05-1.12-3.40
Levered Free Cash Flow
-37.59826.2717.86-49.54-190.92
Unlevered Free Cash Flow
-32.1251.8712.53-31.54-185.48
Updated Feb 25, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q